Arcturus Therapeutics | A Commercial mRNA Medicines Company
May 28, 2024 · Arcturus Therapeutics is a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and …
Arcturus' Pipeline of mRNA Medicines and Vaccines - Arcturus …
In a wholly owned program, Arcturus is developing a messenger RNA (mRNA) medicine to treat ornithine transcarbamylase deficiency, a life-threatening genetic disease that affects over …
Learn About Arcturus - Arcturus Therapeutics
Arcturus’ versatile RNA therapeutics platforms can be applied toward multiple types of nucleic acid medicines including messenger RNA, small interfering RNA, circular RNA, antisense …
RNA Medicines Explained - Arcturus Therapeutics
RNA, DNA and enzymes are rapidly degraded in the gut and in the blood stream. Arcturus’s proprietary LUNAR ® technology can be used to deliver gene editing tools directly into target …
Arcturus Therapeutics Receives U.S. FDA Fast Track Designation …
Jun 1, 2023 · Arcturus’ versatile RNA therapeutics platforms can be applied toward multiple types of nucleic acid medicines including messenger RNA, small interfering RNA, circular RNA, …
Arcturus' RNA & mRNA Proprietary Technologies - Arcturus …
Arcturus Therapeutics Receives Clearance of an Investigational New Drug Application to U.S. Food and Drug Administration for ARCT-032, an Investigational Inhaled mRNA Therapeutic to …
RNA/mRNA Related News & Publications | Arcturus Therapeutics
The latest news and publications for Arcturus Therapeutics, including vaccine news, COVID-19 publications, rare disease scientific publications including Ornithine Transcarbamylase, Cystic …
Arcturus' pipeline includes RNA therapeutic candidates to potentially treat ornithine transcarbamylase (OTC) deficiency and cystic fibrosis (CF), along with its partnered mRNA …
Arcturus Therapeutics to Report Third Quarter Financial Results …
Arcturus' pipeline includes RNA therapeutic candidates to potentially treat ornithine transcarbamylase (OTC) deficiency and cystic fibrosis (CF), along with its partnered mRNA …
Business Development - Arcturus Therapeutics
Arcturus’ versatile RNA therapeutics and LNP Delivery Systems platforms can be applied toward multiple types of nucleic acid medicines including messenger RNA, small interfering RNA, …
- Some results have been removed